Therefore, we hypothesized that lack of MMP7 in these chronic MS lesions contributes to the accumulation of fibronectin, leading to the formation of remyelination‐inhibiting fibronectin aggregates. This evidence concerns the gene MMP7 and myeloid sarcoma.